ArticlePloS one2020

Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.

Seul Ki Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.